Skip to search formSkip to main contentSkip to account menu

Angiotensin II receptor antagonist

Known as: Angiotensin II Receptor Blockers, Angiotensin Receptor Blockers, ARB 
A class of agents that act by selectively inhibiting angiotensin II receptor activation in the renin-angiotensin-aldosterone system. Angiotensin II… 
National Institutes of Health

Related topics

Related topics

5 relations
Angiotensin 2 Receptor Antagonists [MoA]Angiotensin 2 Receptor Blocker [EPC]Pharmacologic Substance

Broader (2)

Angiotensin Receptor AntagonistsReceptor, Angiotensin II

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Sympathetic hyperactivity and clinical outcome in chronic kidney disease patients during standard treatment.
BACKGROUND Sympathetic hyperactivity has been associated with adverse clinical outcome and is common in patients with chronic… 
Highly Cited
2003
Highly Cited
2003
Candesartan, an Angiotensin II Receptor Antagonist, Suppresses Pancreatic Inflammation and Fibrosis in Rats
Angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists attenuate fibrosis in the kidney, heart, and liver… 
Highly Cited
2002
Highly Cited
2002
Randomized controlled crossover study of the effect on proteinuria and blood pressure of adding an angiotensin II receptor antagonist to an angiotensin converting enzyme inhibitor in normotensive…
BACKGROUND Proteinuria and hypertension have independent deleterious effects on the progression of chronic renal disease. The… 
Highly Cited
2000
Highly Cited
2000
Comparative effects of pretreatment with captopril and losartan on cardiovascular protection in a rat model of ischemia-reperfusion.
Highly Cited
1999
Highly Cited
1999
A comparison of the angiotensin II antagonists valsartan and losartan in the treatment of essential hypertension.
Highly Cited
1997
Highly Cited
1997
Angioedema associated with angiotensin II receptor antagonist losartan.
Angioedema has not been associated with losartan therapy in hemodialysis patients, as it has been with angiotensin converting… 
Highly Cited
1996
Highly Cited
1996
Angiotensin II receptor antagonist TCV-116 reduces graft coronary artery disease and preserves graft status in a murine model. A comparative study with captopril.
BACKGROUND Despite the current progress in immunosuppressive regimens, the incidence of graft coronary artery disease (CAD) after… 
Highly Cited
1995
Highly Cited
1995
The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.
Highly Cited
1993
Highly Cited
1993
Potent nonpeptide angiotensin II receptor antagonists. 2. 1-(Carboxybenzyl)imidazole-5-acrylic acids.
The further evolution of the imidazole-5-acrylic acid series of nonpeptide angiotensin II receptor antagonists is detailed (for… 
Highly Cited
1991
Highly Cited
1991
DuP 753 Is a Specific Antagonist for the Angiotensin Receptor
2-n-Butyl-4-chloro-5-hydroxy-methyl-l-[(2′-(lff)-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazol potassium salt (DuP 753) is a… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)